Alza in-line I.V. system
The first Baxter product using the system will not be for "post-surgical pain," as reported in "The Pink Sheet" Oct. 29 (p. 16). Baxter has filed an ANDA but has not disclosed what drug is involved. In addition, the "one-time deduction" for the start-up of Alza's new Vacaville, Calif. manufacturing facility is the initial of two or three quarterly deductions of approximately the same amount. Alza retains an option to acquire Bio-Electro Systems until its stockholder's equity drop below $4 mil., not $6 mil. as was reported....Bristol-Myers Squibb's Pravachol: HMG-CoA reductase inhibitor pravastatin was studied at 40 mg QD (once a day) and 20 mg b.i.d., not four times a day ("The Pink Sheet", Oct. 29, p. 8).
You may also be interested in...
The American Telemedicine Association backed use of more telehealth providers and changes to remote monitoring reimbursements in comments to the US Medicare agency.
STADA Strengthens Specialty Partnership Role Via US Filing
Textualist judges appointed by President Trump during his term may block a potential President Biden’s attempts to shift the government’s legal policies, experts tell Medtech Insight.